Category: Health

  • Nigeria reaffirms continental drug regulation leadership, cites WHO benchmarking success

    Nigeria reaffirms continental drug regulation leadership, cites WHO benchmarking success

    The Federal government has reaffirmed Nigeria’s commitment to leading regulatory excellence on the African continent.

    The government stance becomes imperative because, faced with the urgent need to strengthen its regulatory oversight of medicines and vaccines, Nigeria embarked on the World Health Organization (WHO) Global Benchmarking process in 2018, the Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, said.

    According to her, at the time, the country’s regulatory framework struggled with gaps in efficiency, capacity, and international credibility, issues that affected public trust, delayed access to quality-assured medical products, and hindered local pharmaceutical manufacturing.

    She said the decision to undergo WHO benchmarking was a strategic response to these systemic challenges.

    Adeyeye spoke recently in Abuja during the NAFDAC-hosted first in-person meeting of the WHO Maturity Level 3 (ML3) National Regulatory Authorities (NRAs), that focused on streamlining regulatory pathways, strengthening cooperation, and aligning with broader African Union health goals.

    The in-person meeting brought together the heads of seven other WHO Maturity Level 3 regulatory agencies in Africa, along with experts from across the continent, to share experiences on reliance practices, identify common challenges, and review a draft operational plan for collaborative implementation.

    Explaining that through the Global Benchmarking Tool (GBT), a WHO mechanism developed following the World Health Assembly’s 2014 Resolution 67.20, Adeyeye noted that NAFDAC was evaluated across more than 260 sub-indicators under eight core regulatory functions.

    The regulatory functions, according to her included market authorization, surveillance and control, clinical trial oversight, inspection, laboratory testing, vigilance, licensing, and the strength of the overall regulatory system.

    The outcome of that assessment was sobering: over 800 recommendations were issued, revealing the scope of reform required, she noted.

    In the years that followed, she said NAFDAC implemented the recommendations with strong institutional will, technical investments, and support from partners.

    “In 2022, Nigeria achieved ML3 status, signifying that its regulatory system was now stable, well-functioning, and capable of ensuring the quality, safety, and efficacy of medicines and imported vaccines.

    “This milestone placed Nigeria among a select group of African countries to reach ML3—alongside Tanzania, Ghana, Egypt, South Africa, Senegal, Zimbabwe, and Rwanda.

    “While the achievement reflected national progress, it also underscored a continental opportunity: to build a collaborative regulatory model that reduces duplication, increases access to quality-assured health products, and strengthens Africa’s health sovereignty”, she stressed.

    To seize the opportunity, the DG noted that the eight African ML3 NRAs signed a Memorandum of Understanding (MoU) in February 2025, adding, “The agreement, aimed at formalizing a regulatory reliance mechanism, provides a framework for shared assessments, mutual recognition, and data exchange.

    “It seeks to harmonize regulatory practices across borders and improve efficiency in approving medical products.

    “The MoU aligns with key continental initiatives such as the African Medicines Agency (AMA), the African Medicines Regulatory Harmonization (AMRH) programme, the Pharmaceutical Manufacturing Plan for Africa (PMPA), the Partnership for African Vaccine Manufacturing (PAVM), and the Platform for Harmonized African Health Products Manufacturing (PHAHM).

    “By establishing reliance practices, the ML3 NRAs aim to support local manufacturing, reduce the time and cost of product approvals, and accelerate access to quality medical products.

    “This will support the African Union’s strategy and bring its Pharmaceutical Manufacturing Plan for Africa to reality.

    Read Also: WHO backs new injectable HIV prevention drug

    “To oversee the implementation of this mechanism, a Steering Committee composed of the heads of the eight ML3 NRAs was inaugurated in Abuja”.

    Mr. Richard Tendayi Rukwata, Director-General of the Medicines Control Authority of Zimbabwe, was elected as Chair, while Dr. Ali Ghamrawy of the Egyptian Drug Authority was elected Vice Chair for a two-year term.

    The Committee is responsible for providing strategic guidance, resolving policy-level issues, and ensuring alignment with both national and regional regulatory priorities. Representatives from the AMA, AMRH, and Africa CDC serve as non-voting members, while support partners may participate as observers.

    The Abuja meeting also explored integration with the upcoming Regulatory Information Sharing Portal (RISP), and the role of ML3 agencies in supporting AMA operations and the Africa CDC’s African Pooled Procurement Mechanism (APPM).

    Through this collaboration, the ML3 NRAs are laying the groundwork for a unified regulatory space in Africa—one that reduces inefficiencies, ensures quality, and enables timely access to essential medicines and vaccines across the continent.

  • MLSCN reaffirms sub-regional college’s strategic partnership

    MLSCN reaffirms sub-regional college’s strategic partnership

    The Acting Registrar and Chief Executive Officer of the Medical Laboratory Science Council of Nigeria (MLSCN), Dr. Donald Ofili, has charged fellows of the West African Postgraduate College of Medical Laboratory Science (WAPCMLS) to take an active role in promoting regional cooperation and cross-border knowledge sharing, particularly in advancing diagnostic medicine.

    Dr. Ofili underscored the transformative potential of artificial intelligence and cutting-edge innovations in reshaping medical laboratory services across the continent.

    Ofili, while addressing participants in Lagos on Tuesday at the 5th Regional Conference of WAPCMLS, themed Advancing Diagnostics and Medical Laboratory Services Using Cutting Edge Innovations and AI: African Agenda, said, “The convergence of artificial intelligence and cutting-edge innovations presents unprecedented opportunities for transforming medical laboratory services.

    “It is imperative that WAPCMLS continues to lead the charge in strengthening laboratory advancement across West Africa, harnessing these new frontiers for the benefit of our communities.”

    At the conference that attracted participants and thought leaders from across the region, offering a platform for dialogue, cooperation, and shared action in strengthening laboratory medicine and healthcare delivery across the continent.

    He emphasized the importance of collaboration among professionals across the region in supporting the mission of the West African Health Organization (WAHO).

    Noting that the renewed pledge between MLSCN and WAPCMLS is a strategic move to unify West Africa’s medical laboratory science community around emerging technologies, regulatory reforms, and innovation-driven diagnostics, he said, “This collaborative spirit will be crucial in complementing the vital work of WAHO in promoting health and well-being across our member states.

    “By sharing your expertise and working together, you can collectively elevate the standard of medical laboratory services and contribute to a healthier West Africa.”

    The Acting Registrar used the platform to reaffirm MLSCN’s longstanding commitment to the growth and success of the College, describing the partnership as one rooted in shared ideals of excellence, innovation, and regional integration.

    “The theme of this conference resonates deeply with the mission and vision of MLSCN. As a regulatory body, MLSCN is charged with the critical responsibility of maintaining standards in medical laboratory practice in Nigeria.

    “Our role encompasses ensuring quality, professionalism, and ethical conduct within the profession, ultimately safeguarding public health.”

    Reflecting on the history of the partnership, Dr. Ofili recalled MLSCN’s foundational role in establishing the College over a decade ago.

    “It fills me with pride to recall MLSCN’s pivotal involvement in the conceptualization of WAPCMLS. We were there at the very inception, contributing to the signing of the official document that brought this esteemed College into existence,” he said.

    Read Also: Why accreditation is key to global acceptance of Nigerian lab results, by MLSCN boss

    He commended the College’s rapid growth, describing it as “a beacon of excellence, fostering specialized knowledge and producing highly skilled professionals who are contributing significantly to healthcare in the region.”

    Dr. Ofili assured that MLSCN would continue to support the College’s mandate and push for proper recognition of its Fellows within the public service.

    “MLSCN is not only proud of these achievements but is also ready to further strengthen our collaborations with WAPCMLS. We are committed to working hand-in-hand to fortify the College’s mandate and to ensure that its Fellows receive the due recognition they deserve within the public service,” he said.

    Urging the Fellows to remain ambassadors of excellence, Dr. Ofili said: “Let your professionalism, expertise, and commitment to excellence always reflect the significant contributions and high standards associated with your fellowship status.”

  • Six best ways to stay healthy

    Six best ways to stay healthy

    Simple habits can lead to a healthier life. Adopting a healthy lifestyle can have a profound impact on your overall well-being. By incorporating simple yet effective habits into your daily routine, you can significantly improve your physical and mental health.

    Here are six essential practices to boost your well-being.

    1. Morning sunlight exposure 

    Morning unlight xposure boosts health by regulating the body’s internal clock, improving mood, and producing vitamin D. Spend 10-15 minutes outside in the morning to improve sleep, increase alertness, and support overall well-being.

    2. Regular physical activity 

    Regular physical activity is a key component of a healthy lifestyle. It helps maintain a healthy weight, improves mental health and mood, increases energy levels, and supports bone health. 

    3. Balanced diet 

    A balanced diet is essential for maintaining good health. It involves eating a variety of foods in the right proportions to provide the body with the necessary nutrients. This includes fruits, vegetables, whole grains, lean proteins, and healthy fats. A well-balanced diet supports overall health and reduces the risk of chronic diseases.

    4. Proper hydration 

     Drinking enough water helps regulate body temperature, transport nutrients and oxygen to cells, remove waste products from the body, and support healthy skin, muscles, and organs. Proper hydration can boost energy, improve cognitive function, and support overall well-being.

    5. Good sleep hygiene 

    Good sleep hygiene is crucial for overall health and well-being. It involves practices that help you establish a consistent sleep schedule, improve sleep quality, and increase the amount of restful sleep you get each night.

    Read Also: Six tips to stay healthy during 2025 Ramadan

    This includes maintaining a regular sleep schedule, creating a relaxing bedtime routine, avoiding caffeine and electronics before bedtime, and creating a sleep-conducive environment. Good sleep hygiene can improve physical and mental health, boost energy levels, and enhance cognitive function.

    6. Regular health check-ups

    Regular health check-ups are essential for maintaining good health. They help identify potential health issues early, allowing for timely interventions and preventing more serious problems from developing. Regular check-ups can include screenings for chronic diseases, vaccinations, and health assessments. By staying on top of your health, you can detect health issues early, prevent illnesses, manage chronic conditions, and stay informed about your health. This enables you to take proactive steps towards maintaining your overall well-being.

  • WHO backs new injectable HIV prevention drug

    WHO backs new injectable HIV prevention drug

    The World Health Organisation (WHO) has for the first time recommended the use of injectable lenacapavir (LEN) as a twice-yearly HIV prevention option, marking a breakthrough in the global fight against the disease.

    The announcement was made on Sunday evening during the ongoing 13th International AIDS Society Conference (IAS 2025) on HIV Science in Kigali, Rwanda.

    With just two doses a year, LEN becomes the first long-acting, injectable pre-exposure prophylaxis (PrEP) drug that the WHO is recommending as an additional tool in its HIV prevention arsenal.

    Experts say it offers new hope to people at risk of HIV, especially those who struggle with daily pills due to stigma, access issues or adherence challenges.

    Director-General of WHO, Dr Tedros Adhanom Ghebreyesus, described lenacapavir as “the next best thing” in the absence of an HIV vaccine.

    “Lenacapavir is a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk,” he said.

    “The launch of WHO’s new guidelines, alongside the FDA’s recent approval, marks a critical step forward in expanding access to this powerful tool. WHO is committed to working with countries and partners to ensure this innovation reaches communities as quickly and safely as possible.”

    The new WHO recommendation comes amid growing concern that global HIV prevention efforts are stagnating. In 2024 alone, 1.3 million new infections were recorded, many among key and vulnerable groups such as sex workers, men who have sex with men, transgender people, people who inject drugs, prisoners, and adolescents.

    WHO believes that expanding PrEP options will empower individuals with more control over their health choices. LEN now joins other WHO-approved PrEP methods, including daily oral pills, injectable cabotegravir (CAB-LA), and the dapivirine vaginal ring.

    To support wider access, WHO also introduced new guidance simplifying HIV testing protocols. It now recommends the use of HIV rapid tests for initiating long-acting PrEP options like LEN and CAB-LA.

    The move eliminates the need for complex testing procedures, which have often been a barrier to PrEP delivery, particularly in community-based or low-resource settings.

    With these changes, long-acting PrEP may now be offered in pharmacies, clinics and even via telehealth platforms.

    Despite LEN’s proven effectiveness in clinical trials, access to the drug remains limited outside research settings. WHO is urging governments, donors, and global health organisations to integrate LEN into their national HIV prevention strategies immediately.

    The agency also encouraged countries to collect real-world data on uptake, adherence and impact to inform future scale-up.

    Also at IAS 2025, WHO updated its HIV treatment guidelines to include long-acting injectable cabotegravir and rilpivirine (CAB/RPV) as a switch option for people with full viral suppression who do not have hepatitis B. This could benefit people living with HIV who face difficulties sticking to daily oral medications.

    WHO further recommended integrating HIV services with those for noncommunicable diseases like hypertension, diabetes, and mental health conditions such as depression and anxiety.

    It also introduced new guidance on screening asymptomatic sexually transmitted infections, especially gonorrhoea and chlamydia, among at-risk populations.

    In addition, people living with HIV who contract mpox are now advised to initiate antiretroviral therapy (ART) rapidly, especially if they are ART-naïve or have experienced treatment interruptions.

    The updated guidelines are being launched at a time when international HIV programmes face a reduction in funding.

    WHO’s newly issued operational guidance on sustaining HIV services urges countries to prioritise essential services, monitor disruptions, and adapt delivery models to protect gains made in the fight against the epidemic.

    “We have the tools and the knowledge to end AIDS as a public health problem,” said Dr Meg Doherty, WHO’s Director of Global HIV, Hepatitis and STI Programmes, and incoming Director of Science, Research, Evidence and Quality for Health.

    Read Also: WHO issues first global guidelines on dengue, zika, yellow fever, chikungunya

    “What we need now is bold implementation of these recommendations, grounded in equity and powered by communities.”

    According to WHO, an estimated 40.8 million people were living with HIV by the end of 2024, with around 65 per cent residing in Africa. During the same year, about 630,000 people died from HIV-related illnesses while 1.3 million people, 120,000 of them children, were newly infected.

    However, access to treatment continues to improve, with 31.6 million people on antiretroviral therapy globally in 2024, up from 30.3 million in 2023.

    IAS 2025, which runs from July 13 to 17, is the world’s largest scientific gathering on HIV research. Held in Kigali, the biennial conference features cutting-edge research and critical discussions aimed at influencing policy and accelerating the global HIV response.

    WHO is participating in several high-level sessions to highlight key innovations, equity in access, and the urgent need for sustained health funding.

  • Nigerian doctor wins Dale Abel award at Northwestern, begins cardiology fellowship at Harvard

    Nigerian doctor wins Dale Abel award at Northwestern, begins cardiology fellowship at Harvard

    A Nigerian physician, Dr. Toluwalase Awoyemi, has received the prestigious Dale Abel Award during Northwestern University’s Internal Medicine Residency graduation ceremony in Chicago, United States.

    The award, named after renowned physician-scientist Dr. Dale Abel, is presented each year to a senior resident who demonstrates outstanding mentorship, clinical expertise, research leadership, and community engagement.

    Awoyemi was recognised for his contributions to cardiology research, particularly his work on cardiovascular risk among women, alongside his dedication to teaching and volunteering in underserved communities.

    “This is an incredible honour,” Dr. Awoyemi said in an interview with The Nation. “It reflects the mentorship I’ve received and the patients who have trusted me with their care. From my early days in Osun State to medical school in Ibadan, my PhD at Oxford, and now training in the U.S., I’ve been driven by a single goal: to improve heart health for all, especially vulnerable groups.”

    Born in Osogbo, Osun State, Dr. Awoyemi graduated at the top of his class from the University of Ibadan before proceeding to the University of Oxford as a Rhodes Scholar, where he completed a PhD examining biomarkers and molecular pathways linked to preeclampsia.

    During his residency at Northwestern University’s Feinberg School of Medicine, he earned a reputation as a dedicated clinician and educator, mentoring junior doctors and medical students in cardiovascular care and clinical reasoning. He also took part in preventive health initiatives aimed at reducing heart disease risk in underserved areas.

    A faculty mentor at Northwestern described him as “a model of the physician-scientist we strive to train; brilliant, compassionate, and committed to equity,” noting that his research on cardiovascular risk and his devotion to mentorship captured the essence of the Dale Abel Award.

    Read Also: GWR confirms Nigerian doctor sets new world record for largest drawing

    Awoyemi has since commenced a cardiology fellowship at Massachusetts General Hospital, Harvard Medical School, widely regarded as one of the leading institutions for cardiovascular medicine globally. His focus will include preventive cardiology, cardiovascular risk assessment, and exploring precision-medicine approaches to lower the burden of heart disease worldwide.

    Speaking on his broader aspirations, he expressed hope that his professional journey might serve as motivation for young Nigerians interested in careers in medicine and research. “There is immense talent in Nigeria,” he said. “My journey is proof that with dedication, mentorship, and support, we can lead the world in scientific discovery and patient care. I want to use my training to improve outcomes for women and for all who face barriers to heart health whether in the U.S. or Nigeria.”

    Awoyemi’s recognition comes against the backdrop of cardiovascular disease remaining the leading cause of death globally, with increasing attention being paid to tackling disparities in access to care and health outcomes across different populations and genders.

  • Nigeria, Brazil sign landmark health sector cooperation pact at BRICS summit

    Nigeria, Brazil sign landmark health sector cooperation pact at BRICS summit

    Nigeria and Brazil have signed a landmark health sector cooperation pact at the BRICS summit.

    The Coordinating Minister of Health and Social Welfare,  Prof. Muhammad Ali Pate disclosed this in a statement yesterday.

    The statement reads: ” On the margins of the BRICS Health Ministers’ Meeting in Brazil, I had the honour of signing the Nigeria — Brazil Memorandum of Understanding on Health Collaboration with my esteemed counterpart, Dr. Alexandre Padilha, the Honourable Minister of Health of the Federative Republic of Brazil.”

    This milestone agreement according to the minister  reflects the strategic vision and international cooperation priorities of His Excellency President Bola Ahmed Tinubu, under whose leadership Nigeria is implementing bold and far reaching reforms to strengthen its health system, advance local manufacturing, and reposition the country as a regional hub for pharmaceutical innovation and self-reliance.

    He noted that the “agreement is fully aligned with the Nigerian Health Sector Renewal Investment Initiative (NHSRII) and supports the Presidential Initiative on Unlocking the Healthcare Value Chain (PVAC), a flagship under the NHSRII that aims to expand domestic production, crowd in private investment, and create high quality jobs across the health sector.”

    READ ALSO; Top 10 busiest airports in the world by passenger traffic

    Continuing, he said: “The Memorandum of Understanding establishes a structured framework for cooperation in critical areas, including vaccine access and production, starting with exploring possible government-to-government (G2G) procurement and progressing toward the local manufacturing of vaccines, essential medicines, and pharmaceutical raw materials in Nigeria over time.

    “It further provides avenues for technical cooperation, knowledge exchange, and skills development, all of which are essential to building a resilient, inclusive, and future ready health system for our people both in Nigeria and across Africa.

    “This partnership strengthens the bonds of South — South cooperation and affirms the shared commitment of the Federal Government of Nigeria and the Government of Brazil to building sustainable, high performing health systems that deliver value, equity, and biosecurity for their people.”

    Under the leadership of President Bola Ahmed Tinubu, Prof Pate said “we are laying a generational foundation for a stronger, more inclusive, and investment ready, people-focused health system that is anchored on equity, quality outcomes, resilience, and impact.”

  • Pioneering environmental health science to protect workers

    Pioneering environmental health science to protect workers

    In the evolving landscape of climate change and environmental hazards, few voices resonate with the authority and scientific depth of Anthony Olalekan Akande. A rising scholar in Environmental Health Sciences at The Ohio State University, Akande has carved a niche at the intersection of occupational safety, molecular epidemiology, and climate resilience. From groundbreaking studies on the toxicological effects of pesticides in Nigeria to his current research on the hidden health toll faced by wildland firefighters, he blends rigorous science with a deep sense of societal responsibility. His upcoming presentation at the prestigious International Society for Environmental Epidemiology (ISEE) 2025 conference in Atlanta marks not just a personal milestone but also a global recognition of his work’s potential to shape health policy, workplace safety standards, and community resilience strategies worldwide. He spoke with The Nation’s Samuel Oamen in this virtual interview. Excerpt.

    Our record shows that you had a prior publication with The Nation titled “Nigeria’s Escalating Wildfire Crisis: A National Call to Action.” The article strengthens The Nation’s reputation as a leading voice on pressing environmental issues, engages its readership with impactful content, and supports its mission to inform and influence public policy and national discourse on wildfire management.

    Yes, that piece was reported in May 2025, where I addressed the escalating wildfire crisis in Nigeria and called for urgent national action. The treatise served to raise awareness among policymakers, the general public, and environmental stakeholders about the severity and implications of wildfires. By presenting evidence-based insights and practical recommendations, it aimed to stimulate informed dialogue and encourage collective responsibility. This coverage helped The Nation strengthen its commitment to impactful journalism while empowering readers to support wildfire prevention and environmental stewardship. Interestingly, the positive feedback we received from the audience, coupled with your postings on your social handles, is instrumental to this important interview.

    That said, please could you tell us again, for the benefit of those that might not have known you or heard about you before, tell us more about yourself, your research, and your background?

    Thank you for having me. I am Anthony Akande, currently pursuing my Ph.D. in Environmental Health Sciences at The Ohio State University. My research primarily explores the health impacts of occupational and environmental exposures, with a particular emphasis on wildland firefighters. These workers face unique hazards due to exposure to complex mixtures of air pollutants during wildfire events, which can trigger molecular and physiological changes impacting long-term health. I had my roots in Nigeria, and most of the building blocks of my career were put in place back home. Before relocating to the United States, I was halfway through completing my Ph.D. program in Environmental Science at Obafemi Awolowo University in Nigeria. I had completed a Master of Science in Environmental Control and Management from the Obafemi Awolowo University, where my thesis examined the toxic effects of pesticides on male reproductive health in animal models. The inhalation chamber I modelled for this study is being used by many scientists for several studies involving animal models. Additionally, I graduated with First Class Honors in Environmental Science from Joseph Ayo Babalola University and earned a Bachelor’s degree in Zoology from Obafemi Awolowo University. This multidisciplinary training equips me to approach environmental health challenges from molecular to ecological scales.

    Your multidisciplinary background is impressive. How do these diverse academic experiences influence your current research?

     Thank you for the compliments! Well, I think each degree has contributed to a layer of expertise. My Zoology background gave me a solid foundation in biological systems and parasitology. Environmental science sharpened my understanding of ecological and toxicological principles, while my graduate training emphasized applied environmental health research methods. This combination allows me to tackle complex issues such as how chemical exposures affect human and environmental health, using both classical toxicology and modern molecular tools.

     You have authored several peer-reviewed publications. Can you share how these works have contributed to the scientific community?

     Certainly. I have made significant contributions to the scientific community through peer-reviewed publications in respected journals renowned for their rigorous review processes and broad impact. My research encompasses environmental toxicology, molecular epidemiology, and occupational health, addressing critical issues at the intersection of these fields. For instance, my investigations into pesticide-induced reproductive toxicity in Wistar rats, published in the Saudi Journal of Biomedical Research and East African Scholars Journal of Medical Sciences, provide valuable data relevant to regulatory toxicology. My ecological research on air pollution tolerance in plants, featured in the Journal of Pollution, supports environmental assessment and monitoring initiatives. In infectious disease epidemiology, my analysis of COVID-19 vaccine distribution patterns, published in the Open Journal of Epidemiology, contributes to optimizing public health interventions. Furthermore, pharmacological safety evaluations, as presented in Current Trends in Pharmacology and Clinical Trials, underscore my commitment to translational research with clinical relevance. To me, learning continuously is inevitable. Several other scientific papers are being reviewed and would be showcased on my social handles and other scientific platforms. That said, worthy of note is my work integrating molecular biomarkers and epigenetics within occupational health advances understanding of exposure-associated disease mechanisms, including carcinogenesis, which has been accepted for presentation at the International Conference of Environmental Epidemiology (ISEE), which will be held later in August 2025.

     Your upcoming presentation at the International Society for Environmental Epidemiology (ISEE) in Atlanta is a major achievement. What does this recognition mean to you?

     Absolutely! Getting my abstract accepted in July 2025 to present at ISEE is indeed significant. ISEE is one of the premier international platforms for scientists studying the effects of environmental exposures on human health. This opportunity validates years of dedicated research on occupational exposures and highlights the relevance of my work in shaping scientific discourse and public health policy globally. It positions my findings to influence workplace safety protocols and inspire further research on vulnerable worker populations globally.

    You focus on occupational exposure, e.g., firefighters, farm workers, miners, etc. Could you explain why this group merits particular attention?

    Certainly. Generally, occupational workers are exposed to a complex, often poorly characterized mixture of pollutants from burning vegetation, synthetic materials, and soil particulates. This occupational exposure is unique and intense, especially during prolonged wildfire seasons that are increasing in frequency and severity due to climate change. Such exposures can induce molecular alterations, including changes in gene expression, shifts in DNA methylation, accelerated epigenetic aging, and reductions in pulmonary function. Despite their critical role in safeguarding communities, this workforce has historically been understudied regarding long-term health risks.

    How does your research methodology differ from typical occupational health studies?                                                                                                                                                                                                                                                                                             

    What sets my work apart is the integration of multi-omics approaches. We combine transcriptomics, which studies gene expression patterns, with epigenomics, focusing on DNA methylation, alongside physiological assessments such as spirometry to measure lung function. This comprehensive approach allows us to capture a unified biological response across multiple regulatory levels, providing a more holistic understanding of how exposures impact health than studies focusing on a single biomarker or outcome.

    You’ve also developed skills in genomic data analysis. How does this complement your environmental health research?

    Genomic data analysis is fundamental for deciphering the complex molecular changes induced by environmental exposures. My training in R programming, microarray, and RNA-Seq analysis equips me to manage large, complex datasets and extract meaningful, reproducible insights. This computational expertise bridges raw data to actionable knowledge, ensuring our findings can robustly inform occupational health policies and clinical recommendations.

    Your work seems to have global implications. How do you see it influencing environmental and health policy?

    Man will not cease to interact, whether positively or otherwise, with the environment. This interaction often harms the environment, and as long as this is happening, research findings aimed at preventing or mitigating these adverse impacts will be needed from time to time. The increasing prevalence of wildfires due to climate change places many workers and communities at risk worldwide. Our research provides evidence critical to setting occupational exposure limits, improving personal protective equipment standards, and establishing medical monitoring protocols tailored to high-risk groups. By contributing to climate resilience and public health safety, this work informs policy decisions at the intersection of environment and human health.

    What impact do you hope your ISEE presentation will have?

     I hope it will foster international collaborations and encourage harmonized occupational health studies across different countries and populations. Scientific progress thrives on shared knowledge, constructive critique, and pragmatic application, and I hope to foster such dynamics through this platform you have also acquired multiple certifications.

     How do these enhance your qualifications?

    These certifications, ranging from Radiation Safety to Worker Protection Standards, demonstrate my commitment to laboratory safety, environmental regulations, and ethical research practices. They ensure that my work adheres to best practices and regulatory standards, which is critical for conducting impactful and responsible scientific investigations.

    What advice do you have for early-career scientists aspiring to global impact?

    Pursue questions with scientific rigor and societal relevance. Master relevant skills that can set you apart, like technical skills, e.g., genomic data analysis, but also cultivate interdisciplinary collaborations. Equally important is communicating your science clearly to non-specialists to translate research into real-world impact. Finally, what are your plans following the ISEE conference?

    Post-ISEE, I plan to expand my research to other occupational groups exposed to airborne hazards, including miners and industrial welders. Some of my articles have already been accepted for peer review in reputable journals. Additionally, I am preparing a review article on risk management and healthcare administration to bridge scientific evidence with policy and practice.

    Anthony Olalekan Akande is at the forefront of environmental epidemiology, providing vital insights into how occupational exposures influence molecular and physiological health outcomes. His upcoming ISEE 2025 presentation in Atlanta underscores a growing global recognition of his work and its critical role in advancing worker health and climate resilience worldwide.

  • FG targets wider health insurance coverage, inaugurates NHIA governing council

    FG targets wider health insurance coverage, inaugurates NHIA governing council

    The federal government has expressed renewed optimism about expanding health insurance coverage to more Nigerians through the National Health Insurance Authority (NHIA), citing its central role in improving national health outcomes and delivering on the Renewed Hope Agenda for equitable healthcare access.

    This drive informed the inauguration of the NHIA Governing Council on Friday in Abuja, according to the Coordinating Minister of Health and Social Welfare, Prof. Ali Pate.

    The inauguration comes amid a period of sustained growth for the NHIA, with Health insurance coverage rising to 20 million Nigerians in 2024, up from 16.8 million in 2023, with projections pointing toward surpassing the 2027 target set by the presidency.

    More than 800,000 new beneficiaries have been enrolled in 2025 through the Basic Health Care Provision Fund, bringing the total number supported to 2.67 million.

    Notable interventions include the integration of HIV and tuberculosis care into health insurance through pilot programs in five states, maternal health services reaching over 7,500 women across 200 facilities, and the implementation of a one-hour referral code to streamline service authorisation.

    NHIA has also introduced a long-overdue tariff review, increasing provider payments by 93 percent for capitation and 378 percent for fee-for-service.

    Additionally, the authority has resolved more than 80 percent of beneficiary complaints in 2024, a 21 percent improvement over the previous year and expanded digital systems and accreditation processes.

    Speaking at the inauguration ceremony, Pate emphasised that the newly appointed Council would help consolidate ongoing reforms and scale progress toward achieving universal health coverage.

    He said the appointment of seasoned professionals, led by Senator Dr Ibrahim Yahaya Oloriegbe as Council Chairman, reflects the administration’s commitment to strengthening the NHIA as a cornerstone of Nigeria’s healthcare delivery system.

    Read Also: NHIA, LASG launch emergency obstetric care to reduce maternal deaths

    “The work ahead is substantial, but the opportunity to make a real difference is even greater,” Pate said. “This Council must build on the foundation laid over the past year and a half, during which we have seen meaningful progress in provider payments, inclusion of vulnerable populations, and improved service delivery.”

    He highlighted recent milestones achieved under NHIA’s current management, including increased enrolment, expanded maternal health services, and new initiatives targeting infectious diseases and service efficiency.

    Council Chairman, Senator Oloriegbe, thanked the government for the confidence reposed in him and the board members. Reflecting on his role as a former legislator, he noted that the NHIA Act was one of four health bills he personally sponsored, alongside the Mental Health Act, the amendment to the Psychiatric Hospitals Act, and legislation establishing the Federal College of Alternative and Complementary Medicine.

    “We understand the enormous responsibility before us, and we commit to delivering with diligence and integrity,” he said.

    NHIA Director General (DG), Dr Kelechi Ohiri stressed that achieving universal health coverage required broad collaboration across government tiers, development partners, the private sector, and local communities.

    “This is not the government’s job alone. It will take all of us working together to build a resilient and equitable health system that works for all Nigerians,” Ohiri said.

    With health insurance schemes now active in all 36 states and the FCT, and the Council now fully inaugurated, NHIA is positioned to drive broader reforms, enhance service quality, and ensure that no Nigerian is left behind in the journey toward universal health coverage, the DG noted.

  • Cancer: UNICEF begins HPV vaccination for 9-year-old girls in Osun, urges parental support

    Cancer: UNICEF begins HPV vaccination for 9-year-old girls in Osun, urges parental support

    The United Nations Children’s Fund (UNICEF) has launched the vaccination of 9-year-old girls against the Human Papillomavirus (HPV) in Osun State, as part of efforts to prevent cervical cancer.

    At a two-day stakeholders’ seminar in Osogbo, UNICEF expressed concern over the low acceptance rate of the vaccine among parents and guardians in some local government areas.

    UNICEF Adolescent Development Specialist, Ngozi Sangu, said data shows poor response in several LGAs, prompting the need for renewed sensitisation. “We need to rethink how we reach our parents. Consent is critical, and our outreach methods must evolve to improve vaccine uptake,” Sangu said.

    He disclosed that over 29,000 adolescent girls have so far been vaccinated in partnership with the Osun State Government.

    Also speaking, the Osun State Immunisation Officer, Francisca Olaore, revealed that the overall target is to vaccinate 3 million 9-year-old girls, urging parents to dismiss negative rumours surrounding the vaccine and support efforts to protect the future of the girl child.

    UNICEF Young Leader on HPV advocacy, Rabiah Busari, added that five LGAs—Ifẹ North, Ifẹ South, Ede North, Ede South, and Osogbo—will be directly engaged in the project, with 15 volunteers working over six months to drive awareness and vaccination efforts.

    “A Multi-Age Campaign was done in 2024, and we checked the data of all local governments in Osun State and how many people got vaccinated during this Multi-Age Campaign, and these 5 local governments were identified for their low turnout for this vaccine.

    “So, we are going back to these communities to vaccinate them so that we can see that more 9-year-old girls are vaccinated, prevented from cervical cancer and HPV.”

  • NIPRD, Spark Global collaborate on healthcare innovation

    NIPRD, Spark Global collaborate on healthcare innovation

    National Institute for Pharmaceutical Research and Development (NIPRD) will collaborate with SPARK GLOBAL to guarantee healthcare innovation and self-reliance across Africa and in many parts of the developing world.

    Another advantage of the collaboration will be to train and educate local African scientists to directly address the health needs of the continent.

    NIPRD and SPARK GLOBAL will host the annual SPARK Translational Research Bootcamp and Conference in Abuja, from February 2 to February 6, next year. The SPARK Nigeria program will also be inaugurated during the period.

    The bootcamp and conference will bring together scientists from across African universities and research institutes for training and collaboration using the SPARK translational research model, offering opportunities for education, interaction and collaboration to enable and empower local researchers to develop local capacity leveraging translational research principles.

    Development of a SPARK program in Nigeria will highlight the government’s current priorities on research and development to build value chains in life sciences, pharmaceutical and other relevant contributory sectors for effective healthcare delivery.

    READ ALSO; Russia offers to increase scholarships for Nigerian students 

    The initiative’s goal of developing a local, self-driven discovery and development ecosystem is particularly important in the African setting, where health and socio-economic challenges provide commensurate opportunities for robust collaboration and more impactful interventions.

    The SPARK Translational Research Bootcamp and Conference aims to achieve the following objectives;

    •Educating African scientists and researchers through an intensive translational research bootcamp.

    •Working to close gaps between basic scientific discoveries and their practical applications by building research capacity and collaboration in the Continent.

    •Facilitating opportunities for networking and collaboration amongst stakeholders, scientists, and other key facilitators within the innovation cycle.

    •Training SPARK Africa directors to help establish SPARK centres in host institutions.

    •Leveraging the emergent policies to promote the prioritisation of science, research and development in Africa.

    According to National Coordinator of Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), Dr. Abdu Mukhtar, the essence of PVAC’s work is to strengthen Nigeria’s healthcare value chain from end to end—and this collaboration with SPARK GLOBAL ensures our researchers are equipped from the very start of that value chain. By embedding translational research training within our broader strategy, we are empowering scientists to contextualize discovery into tangible, scalable solutions. Together with our upcoming Pharmaceutical Manufacturing Training Academy in partnership with Empower Swiss, and our nationwide efforts to expand clinical research capacity, this program builds on the momentum the Nigerian government has established to invest in the infrastructure, partnerships, and human capital required to localise innovation and secure long-term health resilience for Nigeria and the continent at large.

    Director-General of NIPRD, Dr. Obi Peter Adigwe said: “This initiative will enhance R&D and innovation capacity to address prevalent diseases across Africa, whilst also catalysing Pan-African collaboration in the development of socioeconomic objectives embedded in respective value chains. The output, structures, and networks that will emerge will enable a template for more impactful knowledge sharing to aid development of evidence-based interventions that address local challenges.